Nuvation Bio Surges on Japanese Approval of Ibtrozi for Lung Cancer StocksToTrade Other
Nuvation Bio Soars As Japan Approves Ibtrozi for Advanced Lung Cancer StocksToTrade Other
Verrica to receive $10M payment as Ycanth gains approval in Japan The Business Journals Other
Nuvation Bio stock gains as Japan approves IBTROZI for lung cancer Investing.com Other
Astellas’ Izervay gains conditional approval in Japan for GA treatment Pharmaceutical Technology Other
Nuvation Bio Says Japan Approves IBTROZI For ROS1+ Advanced Non-small Cell Lung Cancer Treatment Nasdaq Other
NovoCure (NVCR) Gains Japan Approval For Optune Lua® In NSCLC Treatment Combo simplywall.st Other
Novocure (NVCR) Gains Approval in Japan for Cancer Treatment GuruFocus Other